Hepatitis a vaccine and tetanus vaccine (DrugBank: Hepatitis A Vaccine)
1 disease| ID | Disease name (Link within this page) | Number of trials |
|---|---|---|
| 46 | Malignant rheumatoid arthritis | 1 |
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT01947465 (ClinicalTrials.gov) | October 2013 | 22/8/2013 | Immunogenicity and Safety of Vaccinations in Immunocompromised Persons | A Prospective Cohort Study in 6 Swiss Rheumatology Centres and 4 Travel Clinics on the Immunogenicity and Safety of Tetanus and Hepatitis A Vaccine in Patients With Rheumatoid Arthritis, Axial Spondyloarthritis and Vasculitis and Healthy Controls | Arthritis, Rheumatoid;Spondylarthritis;Vasculitis | Biological: Hepatitis A vaccine and tetanus vaccine | University of Zurich | University of Basel;Swiss Tropical & Public Health Institute;University of Bern;University Hospital, Geneva;Cantonal Hospital of St. Gallen;Cantonal Hospital of Aarau, Switzerland | Completed | 18 Years | N/A | Both | 645 | N/A | Switzerland |